STERIS plc

(New York Stock Exchange)
Back to all articles
Bullish +55

STERIS (NYSE:STE) Director Sells $1,239,005.46 in Stock

Dividend Earnings report Insider transaction AI-generated analysis

πŸ“ˆ STERIS reported quarterly earnings of $2.94 per share, beating analyst estimates of $2.68 by $0.26.

πŸ’° Revenue reached $1.59 billion for the quarter, exceeding expectations of $1.56 billion and growing 8.8% year-over-year.

πŸ“‰ Director Mohsen Sohi sold 4,893 shares worth $1,239,005.46, reducing his ownership by 16.76% to 24,305 shares.

πŸ’΅ The company declared a quarterly dividend of $0.69 per share with an ex-dividend date of November 17th.

🏦 Institutional ownership stands at 94.69%, with Benjamin Edwards Inc. increasing its stake by 28.1% in Q3.

πŸ“Š Analyst consensus rating is 'Moderate Buy' with a price target of $276.33, up from previous targets.

πŸ” KeyCorp raised its price objective to $284.00 and maintained an 'overweight' rating on the stock.

πŸ“‰ Wall Street Zen downgraded STERIS from 'strong-buy' to 'buy' in a recent research report.

🏭 STERIS provides infection prevention products and services for healthcare, pharmaceutical, and research industries.

πŸ“ˆ The company's market cap is $24.62 billion with a P/E ratio of 30.07 and a beta of 0.86.

Bullish Signals
  • STERIS beat earnings expectations with $2.94 EPS versus the consensus of $2.68, demonstrating strong operational performance.
  • Revenue of $1.59 billion exceeded analyst forecasts of $1.56 billion, indicating robust demand for its medical equipment and services.
  • The company achieved a net margin of 13.41% and a return on equity of 14.80%, reflecting efficient operations and profitability.
  • Year-over-year revenue growth of 8.8% highlights the company's ability to expand its business in the healthcare sector.
  • Major institutional investors like Benjamin Edwards Inc. increased their stakes, signaling confidence in the company's long-term prospects.
  • The board declared a quarterly dividend of $0.69 per share, providing regular income to shareholders and validating cash flow strength.
  • KeyCorp raised its price target to $284.00 and maintained an 'overweight' rating, reflecting positive analyst sentiment.
Risk Factors
  • Wall Street Zen downgraded the stock from a 'strong-buy' to a 'buy' rating, indicating some analysts see less upside potential.
  • Director Mohsen Sohi sold $1.24 million in shares, representing a 16.76% reduction in his personal holdings.
Full Analysis
STERIS plc (NYSE:STE) reported strong quarterly financial results, posting $2.94 in earnings per share which beat the consensus estimate of $2.68 by $0.26. The company generated revenue of $1.59 billion, surpassing analyst expectations of $1.56 billion, with a net margin of 13.41% and a return on equity of 14.80%. Quarterly revenue increased by 8.8% year-over-year compared to the same period last year when the company reported $2.47 EPS. In addition to its earnings beat, STERIS declared a quarterly dividend payable on December 17th for stockholders of record on November 17th. The dividend amount is set at $0.69 per share, representing an annualized yield of 1.1% and a payout ratio of 32.74%. This financial commitment reflects the company's stable cash flow generation and shareholder return strategy. Institutional investor sentiment remains robust with 94.69% of shares held by institutional investors and hedge funds. Several major firms increased their stakes in the third quarter, including Benjamin Edwards Inc., which boosted its position by 28.1%, and First Trust Advisors LP, which grew its holdings by 2.7%. New positions were also established by Advisors Asset Management Inc., Private Wealth Asset Management LLC, and Private Advisor Group LLC. Wall Street analysts maintain a generally positive outlook on the stock with a consensus rating of 'Moderate Buy' and a price target of $276.33. While Wall Street Zen recently downgraded its rating from 'strong-buy' to 'buy', other firms like KeyCorp, Piper Sandler, and Morgan Stanley have maintained or upgraded their ratings, citing continued confidence in the company's growth trajectory.